Aura Biosciences Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -845.7% | -1,189.3% | – | – | -1,934.7% | – | – | – | – | – | – | – | |
| – | 15.8% | 14.9% | – | – | 23.5% | – | – | – | – | – | – | – | |
| – | 126.6% | 141.5% | – | – | 237.2% | – | – | – | – | – | – | – | |
| – | 98.9% | -330.9% | – | – | -76.1% | – | – | – | – | – | – | – | |
| – | 15.4% | 4.3% | – | – | 24.2% | – | – | – | – | – | – | – | |
| – | -4,383.3% | 457.0% | – | – | 2,398.6% | – | – | – | – | – | – | – | |
| – | 4,522.6% | 12.3% | – | – | 43.9% | – | – | – | – | – | – | – | |
| – | -706.3% | -720.0% | – | – | 507.8% | – | – | – | – | – | – | – | |
| – | -861.1% | -1,193.6% | – | – | -1,958.9% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.